Trial reportScientific reports2025
Efficacy of ultrasound-guided myofascial hydrodissection technique in myofascial pain syndrome of upper trapezius: a randomized controlled trial.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Recent Advances in Ultrasound-Guided Hydrodissection and Dextrose Prolotherapy for Musculoskeletal Pain: A Target-Based State-of-the-Art Narrative Review.Life (Basel, Switzerland) · 2026Review
- Fascia as a Functional System in Health and Disease: From Fundamental Biology to Assessment and Targeted Interventions.International journal of molecular sciences · 2026Review
- Comparison of interfascial plane injection and trigger point injection for upper trapezius myofascial pain syndrome in young women: a prospective cohort study.Frontiers in medicine · 2026Article
- Development and internal validation of a therapeutic effect predictive model for myofascial pain syndrome.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Myofascial pain syndrome (MPS), a chronic musculoskeletal disorder characterized by myofascial trigger points (MTrPs). The objective is to explore the efficacy and safety of ultrasound-guided myofascial hydrodissection technique (UMHT) compared with trigger point injection of lidocaine (TPI) in the patients with MPS of upper trapezius. This randomized clinical trial was conducted at the rehabilitation medicine center of West China Hospital, Sichuan University, with 41 patients between May and October 2024. Patients were assigned to UMHT group (UMHT) or TPI group (1% lidocaine injection). Outcomes were measured at multiple time points using the Visual Analog Scale (VAS, primary), the short-form McGill pain questionnaire (SF-MPQ), and the neck disability index (NDI). Data were analyzed using SPSS v.29. The VAS scores was significantly decreased after receiving either UMHT (Effect sizes r = 0.716; p < 0.001) or TPI (Effect sizes r = 0.604; p < 0.001) during the 12-week follow-up period, while the SF-MPQ and the NDI showed similar positive results. There was no statistically significant difference between UMHT and TPI in pain reduction and function improvement (p > 0.05). No adverse events had been reported. Both UMHT and TPI demonstrate comparable efficacy and safety profiles in managing MPS of upper trapezius.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.